Pacira BioSciences (PCRX) EV to FCF (2011 - 2026)

Pacira BioSciences has reported EV to FCF for 16 years, with the latest figure at 13.53 in Q2 2026.

• On a quarterly basis, EV to FCF fell 79.91% year-over-year to 13.53 in Q2 2026; TTM through Jun 2026 was 4.23, a 21.05% decrease from a year earlier, with the FY2025 full-year figure at 6.04, up 179.39% from the prior year.
• EV to FCF was 13.53 for Q2 2026 at Pacira BioSciences, down from 29.89 in the prior quarter.
• The five-year high for EV to FCF was 135.48 in Q1 2023, with the low at 4.83 in Q3 2024.
• Average EV to FCF over 5 years is 45.37, with a median of 28.57 recorded in 2023.
• The sharpest annual moves came in 2024 and 2025: EV to FCF sank 83.51% in 2024, then soared 279.96% in 2025.
• Over 5 years, EV to FCF stood at 40.62 in 2022, then sank by 30.66% to 28.17 in 2023, then sank by 55.75% to 12.46 in 2024, then soared by 52.39% to 18.99 in 2025, then fell by 28.78% to 13.53 in 2026.
• The last three EV to FCF figures came in at 13.53 (Q2 2026), 29.89 (Q1 2026), and 18.99 (Q4 2025), per Business Quant data.